BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11719282)

  • 1. Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells.
    Lewis JS; Thomas TJ; Klinge CM; Gallo MA; Thomas T
    J Mol Endocrinol; 2001 Dec; 27(3):293-307. PubMed ID: 11719282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
    Teixeira C; Pratt MA
    Mol Endocrinol; 1997 Aug; 11(9):1191-202. PubMed ID: 9259311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW; Nambirajan S; Moffat JG
    Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
    Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary estrogens stimulate human breast cells to enter the cell cycle.
    Dees C; Foster JS; Ahamed S; Wimalasena J
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):633-6. PubMed ID: 9168007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
    Carroll JS; Prall OW; Musgrove EA; Sutherland RL
    J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells.
    Dees C; Garrett S; Henley D; Travis C
    Radiat Res; 1996 Oct; 146(4):444-52. PubMed ID: 8927716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.
    Altucci L; Addeo R; Cicatiello L; Dauvois S; Parker MG; Truss M; Beato M; Sica V; Bresciani F; Weisz A
    Oncogene; 1996 Jun; 12(11):2315-24. PubMed ID: 8649771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
    Musgrove EA; Hamilton JA; Lee CS; Sweeney KJ; Watts CK; Sutherland RL
    Mol Cell Biol; 1993 Jun; 13(6):3577-87. PubMed ID: 8497271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion.
    Cicatiello L; Addeo R; Altucci L; Belsito Petrizzi V; Boccia V; Cancemi M; Germano D; Pacilio C; Salzano S; Bresciani F; Weisz A
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):199-209. PubMed ID: 10940498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
    Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
    Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1).
    Lai A; Sarcevic B; Prall OW; Sutherland RL
    J Biol Chem; 2001 Jul; 276(28):25823-33. PubMed ID: 11337496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.